← Back to headlines
Karyopharm Therapeutics Reports Mixed Q2 Results
Karyopharm Therapeutics has reported mixed financial results for its second quarter but reaffirmed its fiscal year 2026 outlook.
13 Aug, 11:57 — 13 Aug, 11:57
Sources
Showing 1 of 1 sources
